VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CAHCardinal Health, Inc.
$221.77$52.2B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. CAH
  3. Financial Ratios

Cardinal Health, Inc. (CAH) Financial Ratios

30 years of historical data (1996–2025) · Healthcare · Medical - Distribution

View Quarterly Ratios →

P/E Ratio
↓
34.38
↓-12% vs avg
5yr avg: 39.26
089%ile100
30Y Low6.9·High75.1
View P/E History →
EV/EBITDA
↓
18.81
↓-62% vs avg
5yr avg: 49.21
096%ile100
30Y Low4.8·High19.5
P/FCF
↑
28.21
↑+163% vs avg
5yr avg: 10.71
081%ile100
30Y Low5.3·High72.1
P/B Ratio
N/A
—
5yr avg: 9.36
30Y Low0.9·High9.4
ROE
↓
N/A
—
5yr avg: -69.2%
30Y Low-172%·High34%
Debt/EBITDA
↓
3.05
↓-82% vs avg
5yr avg: 16.63
086%ile100
30Y Low0.3·High7.8

Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.

CAH Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

Cardinal Health, Inc. trades at 34.4x earnings, 12% below its 5-year average of 39.3x, sitting at the 89th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 55%. On a free-cash-flow basis, the stock trades at 28.2x P/FCF, 163% above the 5-year average of 10.7x.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$52.2B$40.7B$24.3B$24.8B$14.6B$16.8B$15.3B$14.2B$15.4B$24.9B$25.7B
Enterprise Value$57.7B$46.1B$24.8B$25.9B$15.7B$20.1B$19.3B$19.7B$22.6B$28.5B$28.9B
P/E Ratio →34.3826.0528.5075.06—27.45—10.4060.2819.3318.06
P/S Ratio0.230.180.110.120.080.100.100.100.110.190.21
P/B Ratio—————9.368.532.242.543.653.92
P/FCF28.2121.987.4710.495.338.279.655.926.4531.2910.27
P/OCF21.7716.966.468.714.676.917.805.215.5621.068.66

P/E links to full P/E history page with 30-year chart

CAH EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

Cardinal Health, Inc.'s enterprise value stands at 18.8x EBITDA, 62% below its 5-year average of 49.2x. The Healthcare sector median is 14.2x, placing the stock at a 32% premium on an enterprise-value basis.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—0.210.110.130.090.120.130.140.170.220.24
EV / EBITDA18.8115.0512.6817.92184.3716.01—6.4319.5410.039.33
EV / EBIT25.3419.9219.7834.64—39.95—9.62224.0713.3911.79
EV / FCF—24.937.6210.955.739.9012.178.229.4935.7011.54

CAH Profitability

Margins and return-on-capital ratios measuring operating efficiency

Cardinal Health, Inc. earns an operating margin of 1.0%. ROIC of 3378.7% represents excellent returns on invested capital.

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin3.7%3.7%3.3%3.4%3.6%4.2%4.5%4.7%5.2%5.0%5.4%
Operating Margin1.0%1.0%0.5%0.4%-0.3%0.3%-2.7%1.4%0.1%1.6%2.0%
Net Profit Margin0.7%0.7%0.4%0.2%-0.5%0.4%-2.4%0.9%0.2%1.0%1.2%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE————-172.4%34.1%-90.9%22.0%4.0%19.2%22.2%
ROA3.2%3.2%1.9%0.8%-2.1%1.4%-9.0%3.4%0.6%3.5%4.4%
ROIC3378.7%3378.7%——-16.6%6.5%-34.9%12.3%0.8%15.8%21.8%
ROCE19.2%19.2%13.0%6.6%-4.0%2.8%-24.1%12.1%0.7%12.7%18.0%

CAH Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

Cardinal Health, Inc. carries a Debt/EBITDA ratio of 3.0x, which is moderately leveraged (5% below the sector average of 3.2x). Net debt stands at $5.5B ($9.3B total debt minus $3.9B cash). Interest coverage of 10.8x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity—————3.743.781.271.491.520.84
Debt / EBITDA3.053.052.873.5868.295.35—2.627.783.661.79
Net Debt / Equity—————1.842.230.871.200.510.48
Net Debt / EBITDA1.781.780.240.7612.802.64—1.806.261.241.03
Debt / FCF—2.960.150.470.401.632.532.303.044.411.27
Interest Coverage10.7710.7724.558.89-4.332.79-14.856.960.3110.5713.79

CAH Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

The current ratio of 0.94x is below 1.0, meaning current liabilities exceed current assets — though the company's $3.9B cash position helps mitigate short-term liquidity concerns. The quick ratio of 0.50x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 1.00x to 0.94x over the past 3 years.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio0.940.940.981.001.081.121.101.071.071.341.11
Quick Ratio0.500.500.560.520.570.600.540.540.530.800.58
Cash Ratio0.100.100.140.120.150.120.120.100.080.320.12
Asset Turnover—4.195.034.734.133.653.753.553.423.243.56
Inventory Turnover12.7412.7414.6712.2911.1810.6711.0710.8210.5310.9210.83
Days Sales Outstanding—21.7219.4519.7821.2620.4519.7221.1920.8122.6022.24

CAH Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Cardinal Health, Inc. returns 2.4% to shareholders annually — split between a 0.9% dividend yield and 1.5% buyback yield. The payout ratio of 31.6% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 2.9% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield0.9%1.2%2.1%2.1%3.8%3.4%3.7%4.1%3.8%2.3%2.0%
Payout Ratio31.6%31.6%58.6%159.1%—93.8%—42.3%227.0%44.8%35.9%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield2.9%3.8%3.5%1.3%—3.6%—9.6%1.7%5.2%5.5%
FCF Yield3.5%4.6%13.4%9.5%18.8%12.1%10.4%16.9%15.5%3.2%9.7%
Buyback Yield1.5%1.9%3.1%8.1%6.9%1.2%2.3%4.2%3.6%2.4%2.5%
Total Shareholder Yield2.4%3.1%5.1%10.2%10.7%4.6%6.0%8.3%7.4%4.7%4.5%
Shares Outstanding—$242M$247M$262M$279M$294M$293M$301M$315M$320M$330M

Peer Comparison

Compare CAH with 10 similar companies in its peer group

CompanyMarket CapP/EEV/EBITDAP/FCFGross MarginOp MarginROEROICDebt/EBITDA
CAH logoCAHYou$52B34.418.828.23.7%1.0%—3378.7%3.0
MCK logoMCK$90B19.613.215.83.6%1.6%—254.1%1.2
HSIC logoHSIC$9B24.411.916.029.1%5.7%8.3%7.1%3.4
OMI logoOMI$171M-0.21.7——1.0%-2111.6%1.8%2.6
NXST logoNXST$5B54.77.06.739.0%17.4%5.0%7.4%4.2
JNJ logoJNJ$550B39.419.127.769.1%24.9%20.1%20.7%1.2
PFE logoPFE$143B18.510.315.870.3%24.7%8.9%7.5%3.3
ABT logoABT$154B11.616.124.250.8%16.3%30.9%9.9%1.5
BDX logoBDX$52B24.714.019.545.4%11.8%6.5%4.3%3.8
CVS logoCVS$125B70.714.016.113.8%2.6%2.3%5.0%6.2
HCA logoHCA$84B13.28.610.941.5%15.8%—19.9%3.2
Healthcare Median—22.114.218.563.9%-4.3%-32.6%-11.6%3.2

Peer selection based on competitive and market overlap. Compare multiple stocks →

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into CAH consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CAH — Frequently Asked Questions

Quick answers to the most common questions about buying CAH stock.

What is Cardinal Health, Inc.'s P/E ratio?

Cardinal Health, Inc.'s current P/E ratio is 34.4x. The historical average is 24.2x. This places it at the 89th percentile of its historical range.

What is Cardinal Health, Inc.'s EV/EBITDA?

Cardinal Health, Inc.'s current EV/EBITDA is 18.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.0x.

Is CAH stock overvalued?

Based on historical data, Cardinal Health, Inc. is trading at a P/E of 34.4x. This is at the 89th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is Cardinal Health, Inc.'s dividend yield?

Cardinal Health, Inc.'s current dividend yield is 0.92% with a payout ratio of 31.6%.

What are Cardinal Health, Inc.'s profit margins?

Cardinal Health, Inc. has 3.7% gross margin and 1.0% operating margin.

How much debt does Cardinal Health, Inc. have?

Cardinal Health, Inc.'s Debt/EBITDA ratio is 3.0x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.